On January 28, 2020, Charles Lieber, Chair of the Department of Chemistry and Chemical Biology at Harvard University, was arrested and charged in connection with aiding the People’s Republic of China. Dr. Lieber, who served as the Principal Investigator of the Lieber Research Group at Harvard, specializes in nanoscience and has received more than $15,000,000 in funding from the National Institutes of Health (NIH) and Department of Defense (DOD). The charge stems from fraudulent disclosures allegedly made by Dr. Lieber to federal grantors regarding his financial connections to the Chinese government. The criminal prosecution of Dr. Lieber offers a couple of key lessons for federal grantees.
Regulations, Compliance, & Enforcement
Trending Now
One Part Legal, One Part Behavioral: A Winning Recipe for a More Thoughtful Compliance Program • DOJ Has Agreed Not to Oppose Entry of Judgment On Three Specific Biden-Era Davis-Bacon Act Rules Involving Materialmen, Truckers, and the Application of the Christian Doctrine. • A Decade Later, Escobar Is Still Shaping FCA Cases • Senate Panel Advances NDAA Measure Restricting Defense Contractor Stock Buybacks • AI Is Taking Background Checks from ‘Months to Hours,’ Clearance Agency Says
Arrest of Harvard Professor Reinforces Heightened Scrutiny of Federal Grant Recipients with Connections to China
J Dennis | Shutterstock
Track False Claims Act cases, audit trends, and compliance best practices with our Compliance & Enforcement newsletter, delivering up-to-the-minute intelligence Monday–Saturday — Subscribe here.